ORIGINAL ARTICLE
Evaluation of polymorphisms in microRNA biosynthesis genes and risk of laryngeal cancer in the Polish population
 
More details
Hide details
1
Otolaryngology Department, Medical University of Warsaw, Warsaw, Poland
 
2
Department of Clinical Chemistry and Biochemistry, Medical University of Lodz, Lodz, Poland
 
 
Submission date: 2015-10-13
 
 
Final revision date: 2016-04-25
 
 
Acceptance date: 2016-05-19
 
 
Publication date: 2016-11-25
 
 
Corresponding author
Alicja Nowak   

Department of Clinical Chemistry and Biochemistry Medical University of Lodz Hallera 1 square 90-647 Lodz, Poland
 
 
Pol J Pathol 2016;67(3):283-290
 
KEYWORDS
TOPICS
ABSTRACT
MicroRNAs are the largest group of short regulatory RNAs. They regulate genes participating in many physiological and pathological processes. The role of micro RNAs in cancer development is also considerable. Therefore, the aim of this study was to evaluate the relationship between DROSHA (rs6877842) and DGCR8 (rs417309, rs1640299) gene polymorphisms with risk of occurrence of laryngeal cancer.
The study included 100 patients and 100 healthy subjects. Genomic DNA was extracted from formalin-fixed, paraffin-embedded tissues. Analysis of the gene polymorphisms was performed using TaqMan SNP Genotyping Assay.
The rs417309 AA genotype was found to be correlated with increased risk of larynx cancer. The rs1640299 TG and rs6877842 CG heterozygotes were significantly inversely associated with the presence of larynx cancer. Additionally, rs417309 AA genotype increased the risk of larynx cancer in the T1 stage, and the rs1640299 TG heterozygote occurred more frequently in the control group than those in the T3 and T4 stage.
The rs417309 and rs1640299 polymorphisms of the DGCR8 gene as well as rs6877842 of the DROSHA gene might be associated with a risk of laryngeal cancer occurrence in the Polish population.
REFERENCES (29)
1.
McKaig RG, Baric RS, Olshan AF. Human papillomavirus and head and neck cancer: epidemiology and molecular biology. Head Neck 1998; 20: 250-265.
 
2.
Koufman JA, Burke AJ. The etiology and pathogenesis of laryngeal carcinoma. Otolaryngol Clin North Am 1997; 30: 1-19.
 
3.
Liu RR, Li MD, Li T, et al. Matrix metalloproteinase 2 (MMP2) protein expression and laryngeal cancer prognosis: a meta analysis. Int J Clin Exp Med 2015; 8: 2261-2266.
 
4.
Sun YN, Li Y. Expression of mRNA for membrane-type 1, 2, and 3 matrix metalloproteinases in human laryngeal cancer. Chin Med Sci J 2004; 19: 170-173.
 
5.
Peschos D, Stefanou D, Vougiouklakis T, et al. Cell cycle proteins in laryngeal cancer: role in proliferation and prognosis. J Exp Clin Cancer Res 2005; 24: 431-437.
 
6.
Korkmaz H, Du W, Yoo GH, et al. Prognostic significance of G1 cell-cycle inhibitors in early laryngeal cancer. Am J Otolaryngol 2005; 26: 77-82.
 
7.
Romanowicz-Makowska H, Smolarz B, Gajêcka M, et al. Polymorphism of the DNA repair genes RAD51 and XRCC2 in smoking- and drinking-related laryngeal cancer in a Polish population. Arch Med Sci 2012; 8: 1065-1075.
 
8.
Walczak A, Rusin P, Dziki W, et al. Evaluation of DNA double strand breaks repair efficiency in head and neck cancer. DNA Cell Biol 2012; 31: 298-305.
 
9.
Rusin P, Olszewski J, Morawiec-Bajda A, et al. Role of impaired DNA repair in genotoxic susceptibility of patients with head and neck cancer. Cell Biol Toxicol 2009; 25: 489-497.
 
10.
Lee RC, Ambros V. An extensive class of small RNAs in Caenorhabditis elegans. Science 2001; 294: 862-864.
 
11.
Lagos-Quintana M, Rauhut R, Lendeckel W, Tuschl T. Identification of novel genes coding for small expressed RNAs. Science 2001; 294: 853-858.
 
12.
Friedländer MR, Lizano E, Houben AJ, et al. Evidence for the biogenesis of more than 1,000 novel human microRNAs. Genome Biol 2014; 15: R57.
 
13.
Londin E, Loher P, Telonis AG, et al. Analysis of 13 cell types reveals evidence for the expression of numerous novel primate- and tissue-specific microRNAs. Proc Natl Acad Sci U S A 2015; 112: E1106-E1115.
 
14.
Williams AE. Functional aspects of animal microRNAs. Cell Mol Life Sci 2008; 65: 545-562.
 
15.
Ouellet DL, Perron MP, Gobeil LA, et al. MicroRNAs in gene regulation: when the smallest governs it all. J Biomed Biotechnol 2006; 2006: p. 69616.
 
16.
Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004; 116: 281-297.
 
17.
Zhang B, Pan X, Cobb GP, Anderson TA. microRNAs as oncogenes and tumor suppressors. Dev Biol 2007; 302: 1-12.
 
18.
Cho SH, Ko JJ, Kim JO, et al. 3’-UTR Polymorphisms in the MiRNA Machinery Genes DROSHA, DICER1, RAN, and XPO5 Are Associated with Colorectal Cancer Risk in a Korean Population. PLoS One 2015; 10: e0131125.
 
19.
Jiang Y, Chen J, Wu J, et al. Evaluation of genetic variants in microRNA biosynthesis genes and risk of breast cancer in Chinese women. Int J Cancer 2013; 133: 2216-2224.
 
20.
Rah H, Jeon YJ, Lee B, et al. Association of polymorphisms in microRNA machinery genes (DROSHA, DICER1, RAN, and XPO5) with risk of idiopathic primary ovarian insufficiency in Korean women. Menopause 2013; 20: 1067-1073.
 
21.
Li X, Tian X, Zhang B, Chen J. Polymorphisms in micro RNA-related genes are associated with survival of patients with T-cell lymphoma. Oncologist 2014; 19: 243-249.
 
22.
Lin RJ, Lin YC, Chen J, et al. microRNA signature and expression of Dicer and Drosha can predict prognosis and delineate risk groups in neuroblastoma. Cancer Res 2010; 70: 7841-7850.
 
23.
Guo X, Liao Q, Chen P, et al. The microRNA-processing enzymes: Drosha and Dicer can predict prognosis of nasopharyngeal carcinoma. J Cancer Res Clin Oncol 2012; 138: 49-56.
 
24.
Sand M, Gambichler T, Skrygan M, et al. Expression levels of the microRNA processing enzymes Drosha and dicer in epithelial skin cancer. Cancer Invest 2010; 28: 649-653.
 
25.
Yan, M., Huang HY, Wang T, et al. Dysregulated expression of dicer and drosha in breast cancer. Pathol Oncol Res 2012; 18: 343-348.
 
26.
Zhang X, Cairns M, Rose B, et al. Alterations in miRNA processing and expression in pleomorphic adenomas of the salivary gland. Int J Cancer 2009; 124: 2855-2863.
 
27.
Sand M, Skrygan M, Georgas D, et al. Expression levels of the microRNA maturing microprocessor complex component DGCR8 and the RNA-induced silencing complex (RISC) components argonaute-1, argonaute-2, PACT, TARBP1, and TARBP2 in epithelial skin cancer. Mol Carcinog 2012; 51: 916-922.
 
28.
Yang H, Dinney CP, Ye Y, et al. Evaluation of genetic variants in microRNA-related genes and risk of bladder cancer. Cancer Res 2008; 68: 2530-2537.
 
29.
Lin J, Horikawa Y, Tamboli P, et al. Genetic variations in microRNA-related genes are associated with survival and recurrence in patients with renal cell carcinoma. Carcinogenesis 2010; 31: 1805-1812.
 
eISSN:2084-9869
ISSN:1233-9687
Journals System - logo
Scroll to top